Some patients stop Ozempic and other weekly GLP-1 drugs despite improved blood sugar results. Persistent nausea, appetite suppression, treatment fatigue, and lifestyle burden may all contribute to long-term discontinuation.
Some patients who switch to Ozempic or Mounjaro eventually return to older GLP-1 drugs like Byetta. Side effects, familiarity, insurance coverage, and treatment routines all influence long-term diabetes medication adherence.
Many patients who once relied on Byetta have transitioned to weekly GLP-1 drugs like Ozempic and Mounjaro. The shift reflects more than convenience — it highlights how injection burden, meal timing, travel logistics, and adherence shape modern diabetes care.